Table 5.
Pairwise meta-analysis of SF-36.
| Comparison | Number | SMD (95% CI) | p | I 2 (%) |
|---|---|---|---|---|
| A VS I | 4 | 8.82 (5.62, 12.02) | <0.00001 | 46 |
| A VS J | 1 | 6.20 (0.42, 11.98) | 0.04 | — |
| A VS H | 1 | 8.75 (−0.66, 18.16) | 0.07 | 0 |
| A VS G | 1 | 14.00 (8.20, 19.80) | <0.00001 | — |
| B VS I | 1 | 14.35 (3.79, 24.91) | 0.008 | — |
| B VS G | 2 | 17.84 (15.31, 20.36) | <0.00001 | 91 |
| E VS J | 1 | 3.60 (−3.59, 10.79) | 0.33 | — |
| E VS H | 1 | 9.90 (1.01, 18.79) | 0.03 | — |
Note. A: acupuncture; B: electroacupuncture; E: acupoint catgut embedding; G: sham acupuncture; H: domperidone; I: itopride; J: mosapride.